AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like Genentech's Hemlibra Data Continues to Wow at ASH December 10, 2017 Biotech Startup Formed by 4 Ex-Pfizer Employees Inks Deal With Former Employer January 22, 2018 Biotech Loses a Legend: Founder and Longtime CEO Dies at 71 May 14, 2017
